Adze-1.17.C

N/A

Report date: 2023/03/04 19:33:11

Base Information

Drug NameAdze-1.17.C
Drug Alias NameAdze-1.17.C
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesAdze Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesAdze Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A